Magnetic resonance imaging (MRI) contrast agents are pharmaceuticals used widely in MRI
examinations. Gadoliniumbased MRI contrast agents (GBCAs) are by far the most …

Objective The aim of this study was to evaluate the safety profile of gadoterate meglumine
from clinical trials, postmarketing observational studies, and pharmacovigilance reports of …

Purpose To investigate the safety of gadoterate meglumine and identify the incidence of
nephrogenic systemic fibrosis (NSF). Materials and Methods An international prospective …

Objectives Recurrent peripheral vestibulopathy (RPV) is a public health problem, yet the
aetiology remains unclear. Recent developments in MRI of endolymphatic hydrops (EH) …

Abstract Contrast-enhanced MR (CE-MR) imaging is required to improve lesion detection
and characterization and to increase diagnostic confidence. This study aims to evaluate the …

Objectives To investigate the safety and tolerability of gadobutrol at the recommended dose
in patients requiring contrast-enhanced magnetic resonance imaging/angiography …

Objective To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-
enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high …

Background The EU gadolinium-based contrast agents (GBCA) market has changed in
recent years due to the European Medicines Agency decision to suspend the marketing …

Objective The aim of this study was to provide a systematic safety analysis of gadobutrol
after more than 29 million applications in clinical routine. Materials and Methods Forty-two …

Magnetic resonance imaging contrast agents can be classified according to their chemical
structures, their effect on the local magnetic field, or by their contrast mechanism. Two main …